menu
    • menu

    Company profile for Cali Biosciences

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CaliBio is an international biopharmaceutical company dedicated to the research and development of innovative drugs. We have an international team of scientific research and management talents and is developing new drugs based on several licensed technology platforms. We focus on the R&D of perioperative drugs. The product pipeline includes new drugs in the fields of anesthesia, analgesia and anti-inflammatory. In the future, ...
    CaliBio is an international biopharmaceutical company dedicated to the research and development of innovative drugs. We have an international team of scientific research and management talents and is developing new drugs based on several licensed technology platforms. We focus on the R&D of perioperative drugs. The product pipeline includes new drugs in the fields of anesthesia, analgesia and anti-inflammatory. In the future, we will also promote the commercialization of products to fully respond to the unmet market demand.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cali BiosciencesChina Flag
    Country
    Country
    China
    Address
    Address
    401-403A, Wanwei Building, No. 5, Gongye 5th Road, Nanshan District, Shenzhen
    Telephone
    Telephone
    0755-26683909
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.calibiosciences.com/EN
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cali-biosciences/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cali Bio Announces Successful Hernia Phase 2 Results Publication
    Cali Bio Announces Successful Hernia Phase 2 Results Publication

    21 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cali-biosciences-announces-publication-of-successful-phase-2-study-results-in-hernia-302151218.html

    PR NEWSWIRE
    21 May 2024
    Share Share
    Cali Biosciences Initiates Second Phase III Study of CPL-01
    Cali Biosciences Initiates Second Phase III Study of CPL-01

    05 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cali-biosciences-initiates-second-phase-iii-study-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-and-presents-consistent-and-predictable-pk-results-across-multiple-surgeries-301841948.html

    PR NEWSWIRE
    05 Jun 2023
    Share Share
    Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine)
    Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine)

    18 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cali-biosciences-initiates-phase-iii-studies-of-cpl-01-long-acting-ropivacaine-to-decrease-post-operative-pain-and-reduce-or-eliminate-opioid-use-301801255.html

    PR NEWSWIRE
    18 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search